Review article · 2025 · Open access

Engaging T cells for cleanup

Roman V. Mungalov, N.V. Mushenkova, Dmitriy M. Chudakov, Maria A. Turchaninova

Frontiers in Immunology, 16, 1551424 · Published 6 May 2025 · DOI 10.3389/fimmu.2025.1551424

Open PDFView at the publisherCite this paper

In brief

“Engaging T cells for cleanup” is a 2025 review article by Roman V. Mungalov and 3 co-authors, published in Frontiers in Immunology. OpenAlex counts 14 citations as of 20 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Immunology.

Citations
14
Most cited in
2026 (8)
Field-weighted impact
1.30
References
131
Authors
4

Abstract

T-cell engagers represent a transformative approach to cancer immunotherapy leveraging bispecific and multispecific antibody constructs to redirect T-cell cytotoxicity toward malignant cells. These molecules bridge T cells and tumor cells by simultaneously binding CD3 on T cells and tumor-associated antigens on cancer cells, thereby enabling precise immune targeting even in immunologically "cold" tumors. Recent advancements include conditional T-cell engagers activated by tumor microenvironment proteases to minimize off-tumor toxicity as well as T-cell receptor-based engagers targeting intracellular antigens via MHC presentation. Clinical successes, such as Kimmtrak in metastatic uveal melanoma, underscore good potential of these modalities, while challenges persist in the management of cytokine release syndrome, neurotoxicity, and tumor resistance. Emerging multispecific engagers are aimed at enhancing efficacy via incorporation of costimulatory signals, thus offering a promising trajectory for next-generation immunotherapies. T-cell engagers are also gaining attention in the treatment of autoimmune disorders, where they can be designed to selectively modulate pathogenic immune responses. By targeting autoreactive T or B cells, T-cell engagers hold promise for restoring immune tolerance in such conditions as HLA-B*27-associated autoimmunity subtypes, multiple sclerosis, rheumatoid arthritis, and type 1 diabetes mellitus. Engineering strategies that incorporate inhibitory receptors or tissue-specific antigens may further refine T-cell engagers' therapeutic potential in autoimmunity, by minimizing systemic immunosuppression while preserving immune homeostasis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mungalov, R. V., Mushenkova, N., Chudakov, D. M., & Turchaninova, M. A. (2025). Engaging T cells for cleanup. Frontiers in Immunology, 16, 1551424. https://doi.org/10.3389/fimmu.2025.1551424

MLA 9

Mungalov, Roman V., et al. “Engaging T cells for cleanup.” Frontiers in Immunology, vol. 16, 2025, p. 1551424. https://doi.org/10.3389/fimmu.2025.1551424.

Chicago

Mungalov, Roman V., N.V. Mushenkova, Dmitriy M. Chudakov, and Maria A. Turchaninova. 2025. “Engaging T cells for cleanup.” Frontiers in Immunology 16: 1551424. https://doi.org/10.3389/fimmu.2025.1551424.

Harvard

Mungalov, R. V. et al. (2025) ‘Engaging T cells for cleanup’, Frontiers in Immunology, 16, p. 1551424. doi:10.3389/fimmu.2025.1551424.

IEEE

R. V. Mungalov, N. Mushenkova, D. M. Chudakov, and M. A. Turchaninova, “Engaging T cells for cleanup,” Frontiers in Immunology, vol. 16, p. 1551424, 2025, doi: 10.3389/fimmu.2025.1551424.

BibTeX

@article{mungalov2025engaging,
  title     = {{Engaging T cells for cleanup}},
  author    = {Mungalov, Roman V. and Mushenkova, N.V. and Chudakov, Dmitriy M. and Turchaninova, Maria A.},
  journal   = {Frontiers in Immunology},
  year      = {2025},
  volume    = {16},
  pages     = {1551424},
  doi       = {10.3389/fimmu.2025.1551424},
  url       = {https://doi.org/10.3389/fimmu.2025.1551424}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers

  • T-cell engagers
  • bispecific antibodies
  • multispecific antibodies
  • cancer immunotherapy
  • CD3
  • tumor-associated antigens
  • cold tumors
  • MHC presentation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Mungalov, R. V., Mushenkova, N., Chudakov, D. M., & Turchaninova, M. A. (2025). Engaging T cells for cleanup. Frontiers in Immunology, 16, 1551424. https://doi.org/10.3389/fimmu.2025.1551424

How many times has this paper been cited?

14 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Immunology: sign in and open the PDF from this page.

Who wrote this paper?

Roman V. Mungalov, N.V. Mushenkova, Dmitriy M. Chudakov, Maria A. Turchaninova.

What is the DOI of this paper?

10.3389/fimmu.2025.1551424, permanently at https://doi.org/10.3389/fimmu.2025.1551424. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.